New research has identified the enzyme glutamate dehydrogenase 1 (GLUD1) as a new therapeutic target for Duchenne muscular dystrophy (DMD).

At a time of global upheaval and slowdown in luxury spending, the Italian fashion group parent to the Imperial, Dixie and Please brands is pushing ahead.